Cargando…
Bone marrow-derived mesenchymal stem cells improve cognitive impairment in an Alzheimer’s disease model by increasing the expression of microRNA-146a in hippocampus
Alzheimer’s disease (AD) is characterized by the accumulation of amyloid-β and tau. We previously reported that administration of bone marrow mesenchymal stem cells (BM-MSCs) ameliorates diabetes-induced cognitive impairment by transferring exosomes derived from these cells into astrocytes. Here, we...
Autores principales: | Nakano, Masako, Kubota, Kenta, Kobayashi, Eiji, Chikenji, Takako S., Saito, Yuki, Konari, Naoto, Fujimiya, Mineko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7330036/ https://www.ncbi.nlm.nih.gov/pubmed/32612165 http://dx.doi.org/10.1038/s41598-020-67460-1 |
Ejemplares similares
-
An enriched environment prevents cognitive impairment in an Alzheimer’s disease model by enhancing the secretion of exosomal microRNA-146a from the choroid plexus
por: Nakano, Masako, et al.
Publicado: (2020) -
Bone marrow-derived mesenchymal stem cells improve diabetes-induced cognitive impairment by exosome transfer into damaged neurons and astrocytes
por: Nakano, Masako, et al.
Publicado: (2016) -
An enriched environment prevents diabetes-induced cognitive impairment in rats by enhancing exosomal miR-146a secretion from endogenous bone marrow-derived mesenchymal stem cells
por: Kubota, Kenta, et al.
Publicado: (2018) -
p16(INK4A)-expressing mesenchymal stromal cells restore the senescence–clearance–regeneration sequence that is impaired in chronic muscle inflammation
por: Chikenji, Takako S., et al.
Publicado: (2019) -
Mesenchymal stem cell therapy ameliorates diabetic nephropathy via the paracrine effect of renal trophic factors including exosomes
por: Nagaishi, Kanna, et al.
Publicado: (2016)